Inventor
GRIFFITHS-JONES CHARLOTTE MARY
GB23 patents
⚠️ This page may combine multiple inventors who share the name “GRIFFITHS-JONES CHARLOTTE MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
9 patentsUS9783538B2Oct 10, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD12 citations91
US10618895B2Apr 14, 2020
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD4 citations83
US9676768B2Jun 13, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD8 citations83
US11866428B2Jan 9, 2024
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD2 citations72
US11643410B2May 9, 2023
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD1 citations72
US11225476B2Jan 18, 2022
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD3 citations72
US11603367B2Mar 14, 2023
Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
ASTEX THERAPEUTICS LTD2 citations66
US12202828B2Jan 21, 2025
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD0 citations62
US12091409B2Sep 17, 2024
Ether linked triazoles as NRF2 activators
ASTEX THERAPEUTICS LTD0 citations61
SAXTY GORDON
4 patentsUS8859582B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON7 citations83
US8076354B2Dec 13, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON9 citations83
US8071614B2Dec 6, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON16 citations83
US8859583B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON0 citations51
BERDINI VALERIO
3 patentsUS8895745B2Nov 25, 2014
Bicyclic heterocyclic compounds as FGFR inhibitors
BERDINI VALERIO33 citations92
US8513276B2Aug 20, 2013
Imidazo[1,2-a]pyridine compounds for use in treating cancer
BERDINI VALERIO8 citations82
US8796244B2Aug 5, 2014
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
BERDINI VALERIO2 citations50
OTSUKA PHARMA CO LTD
3 patentsUS10457669B2Oct 29, 2019
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD5 citations82
US11001575B1May 11, 2021
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD4 citations71
US11939321B2Mar 26, 2024
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD0 citations61
GLAXOSMITHKLINE IP DEV LTD
3 patentsUS11059816B2Jul 13, 2021
Ether linked triazoles as NRF2 activators
GLAXOSMITHKLINE IP DEV LTD0 citations61
US10364256B2Jul 30, 2019
Biaryl pyrazoles as NRF2 regulators
GLAXOSMITHKLINE IP DEV LTD2 citations59
US10351530B2Jul 16, 2019
Arylcyclohexyl pyrazoles as NRF2 regulators
GLAXOSMITHKLINE IP DEV LTD0 citations40